Top Biotech Companies in Denver & Boulder, CO (64)
ALTEN Technology USA is an engineering consulting company that provides innovative solutions for engineering, IT, and product development projects across the product life cycle. For decades, ALTEN Technology USA has been helping clients develop products that are changing the world, whether by shaping the future of space exploration, saving lives with medical devices that set new standards of care or...
Forge Biologics is a gene therapy contract development and manufacturing organization (CDMO) and clinical-stage therapeutics developer. The company helps scientists, physicians, biotechnology and pharmaceutical companies, and patient groups bring life-changing gene therapies from concept to patients. Its end-to-end capabilities include plasmid and AAV manufacturing, process and analytical development, cGMP production, fill and finish, and integrated regulatory support for transformative medicines...
Foresight Diagnostics is a precision medicine company developing a novel liquid biopsy test for the measurement of minimal residual disease (MRD) for aid in patient management that is funded by leading diagnostics VC firms in Silicon Valley. Foresight’s cell-free DNA testing platform was developed in the labs of two prominent professors at Stanford University and is backed by several major...
What if you could repair broken genes? That is the question we ask ourselves every day at Editas Medicine. We’re a leading genome editing company focused on translating the power and promise of our proprietary genome editing systems into medicines to help transform the lives of people with genetically-defined diseases. Our goal is to discover, develop, manufacture, and commercialize transformative...
Enrich is the leader in biotech and pharmaceutical portfolio management software, used in over half of the top 10 life sciences companies to value and manage portfolios of high risk, high investment assets. Our proprietary suite of tailored analytics and flexible on-demand visualizations are ideally suited for portfolio management.
Versiti is a nonprofit blood health organization dedicated to improving patient health through discovery, diagnosis, and treatment. It collects, tests, and distributes blood products to hospitals across five Midwestern states; coordinates organ, tissue, and eye donation programs; provides specialized diagnostic laboratory and bleeding-disorder services; and conducts biomedical research into leukemia, hemophilia, sickle cell disease, gene and cell therapy, and personalized...
With 30+ years of experience, 28+ locations, and 2,000+ clinical studies conducted, Elite Clinical Network (ECN) is a trusted leader in clinical research. Our dedicated network of research sites is built on personalized service, investigator diversity, and rigorous quality processes to ensure excellence in every study. Backed by a professional corporate management team, we partner with top physicians across diverse specialties...
Zynex Monitoring Solutions "ZMS" is a engineering and I.T. branch of Zynex, Inc. (NASDAQ: ZYXI). We invent, research, and engineer non-invasive medical device solutions for monitoring physiological changes. Our premiere FDA-approved product - The Zynex Monitoring System (CM-1500) - is an innovative, non-invasive monitoring device, designed to monitor relative fluid volume changes.
GT Molecular was created to develop new molecular detection technology for cancer research and harmful pathogen detection. We have recently focused these powerful tools on the detection of SARS-CoV-2 in wastewater to support communities around the country with their monitoring programs. Ultrasensitive Molecular Assays, Digital PCR and qPCR Tests End-to-End solutions for cancer detection and waterborne pathogens including SARS-CoV-2. Detect as...
Trusted by the world's leading organizations, Point B is a consulting firm that works at the intersection of expertise, industry insight, and transformative technology. This collaborative approach enables you to solve your most important challenges, by bringing together the right mix of talent and technology to deliver greater value and impact. With over 850 associates in the US and 3000+...
Materion (NYSE: MTRN) is one of the world’s premier advanced materials solutions providers. At Materion, we are committed to developing, manufacturing and marketing highly engineered advanced materials for global customers across a wide range of markets, including consumer electronics, defense and science, industrial and aerospace, automotive electronics, telecommunications infrastructure, appliances, medical and energy. Our products, processes and expertise help enable...
Drug discovery just got a modern upgrade. Pluto is the collaborative, AI-powered solution empowering scientific teams to do target and biomarker discovery, faster than ever before. Build your biomarker and target lists, track status, priority, and evidence in powerful reports. Visualize and analyze multi-omics data sets with no coding required, and create compelling figures for high-impact presentations. Integrate the wealth...
Sartorius is a leading international partner of life sciences research and biopharmaceutical manufacturing. We help our customers #SimplifyProgress from drug discovery to manufacturing so that more people can have access to better medicine. With this, we are #PartOfTheSolution in the fight against diseases worldwide. With innovative laboratory instruments and consumables, the our Lab Products & Services division focuses on laboratories performing...
Sartorius's Top Stability & Growth Strengths
Strong Market Position & Advantage: Independent market analyses repeatedly characterize Sartorius as a top‑tier leader in single‑use bioprocessing, particularly in single‑use bioreactors, bags/assemblies, and integrated upstream platforms. Broad scale from bench to 2,000‑L, a large installed base, and continued capacity expansions reinforce this position.
Strong Revenue Growth: Company disclosures indicate sales grew 7.6% in constant currencies in 2025 to about €3.54 billion, with Q1 2026 up 7.5% and full‑year 2026 guidance of 5–9% growth. Order intake recovery from late 2024 and momentum in Bioprocess Solutions underpin this trend.
Profitability: Underlying EBITDA increased faster than sales in 2025, with margin near 30%, and management expects robust margins into 2026. Improving cash generation and recurring consumables contribute to sustained profitability.
Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place. Yes, we love...
Smith & Nephew's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show mid-single-digit underlying growth through 2024–2025, with management reiterating guidance for continued growth in 2026. Early 2026 updates indicate broad-based contributions across units despite some subsegment variability.
Profitability: Trading profit and margins improved, supported by execution of the 12‑Point Plan and the transition to the RISE strategy. Management is guiding to further profit growth alongside higher returns.
Healthy Cash Flow: Free cash flow strengthened in 2025 with guidance for robust generation in 2026. Share repurchases completed and newly announced buybacks signal confidence and disciplined capital allocation.
We believe in the power of technology to improve lives, from new opportunities and mission-critical functionality to user experience. Our team is proud to partner with passionate companies focused on reducing energy consumption, curing disease, improving education, building smart cities, and more – and with leading Cloud providers, including Amazon Web Services (AWS) and Microsoft Azure.
At Enveda, we are systematically translating molecules found in medicinal plants into new drugs for challenging diseases. Our platform harnesses nature's complexity with the help of cutting-edge advancements in knowledge graphs, machine learning, and metabolomics.
EMSL Analytical, Inc. is a leading environmental testing firm providing a wide array of analytical services for environmental investigations, including asbestos, microbiology, lead paint, environmental chemistry, indoor air quality, and industrial hygiene. They also offer materials testing, characterization, and forensic laboratory services.
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development. We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to...
Ensign-Bickford Industries, Inc. (EBI), founded in 1836, is a privately-owned high technology conglomerate focused in space & defense, pet food science, and biotechnology. We participate in businesses that are relevant to the future of the world and have multigenerational growth prospects. EBI companies are unified by a common shared operating system and a common set of values.
EcoGen BioSciences is a producer, manufacturer and supplier of compliant specialty hemp ingredients globally. Our platform of in-house processing and extraction provides innovative bulk and private label service opportunities for our customers. Curated from our processing and extraction facilities, our team has developed a broad range of the highest quality hemp derived cannabinoids and customized formulations for the beverage, food, cosmetics,...































